Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Inoue

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
American Journal of Epidemiology|November 24, 2020
Behavioral Problems at Age 11 Years After Prenatal and Postnatal Exposure to Acetaminophen: Parent-Reported and Self-Reported OutcomesKosuke Inoue, Beate Ritz, Andreas Ernst, et al.
Journal of the Endocrine Society|December 22, 2021
Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 PandemicKosuke Inoue, Jaeduk Yoshimura Noh, Ai Yoshihara, et al.
Endocrine Journal|May 6, 2024
Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracilJaeduk Yoshimura Noh, Kosuke Inoue, Nami Suzuki, et al.
Clinical and Experimental Nephrology|April 9, 2013
Serum level of soluble (pro)renin receptor is modulated in chronic kidney diseaseKazu Hamada, Yoshinori Taniguchi, Yoshiko Shimamura, et al.
Plos One|December 11, 2013
5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivoYoshio Terada, Keiji Inoue, Tatsuki Matsumoto, et al.
Endocrine Journal|September 24, 2023
Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal of a predictive scoreNatsuko Watanabe, Jaeduk Yoshimura Noh, Ai Kozaki, et al.
Plos One|April 28, 2022
Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppressionHaremaru Kubo, Yuya Tsurutani, Kosuke Inoue, et al.
Scientific Reports|December 11, 2023
Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center studyTakumi Kitamoto, Tsuyoshi Idé, Yuta Tezuka, et al.
Environmental Research|August 27, 2020
Prenatal exposure to perfluoroalkyl substances and behavioral difficulties in childhood at 7 and 11 yearsJiajun Luo, Jingyuan Xiao, Yu Gao, et al.
Journal of the American Heart Association|August 5, 2024
Primary Aldosteronism and Risk of Cardiovascular Outcomes: Genome-Wide Association and Mendelian Randomization StudyKosuke Inoue, Tatsuhiko Naito, Ryosuke Fuji, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
American Journal of Epidemiology|November 24, 2020
Behavioral Problems at Age 11 Years After Prenatal and Postnatal Exposure to Acetaminophen: Parent-Reported and Self-Reported OutcomesKosuke Inoue, Beate Ritz, Andreas Ernst, et al.
Journal of the Endocrine Society|December 22, 2021
Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 PandemicKosuke Inoue, Jaeduk Yoshimura Noh, Ai Yoshihara, et al.
Endocrine Journal|May 6, 2024
Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracilJaeduk Yoshimura Noh, Kosuke Inoue, Nami Suzuki, et al.
Clinical and Experimental Nephrology|April 9, 2013
Serum level of soluble (pro)renin receptor is modulated in chronic kidney diseaseKazu Hamada, Yoshinori Taniguchi, Yoshiko Shimamura, et al.
Plos One|December 11, 2013
5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivoYoshio Terada, Keiji Inoue, Tatsuki Matsumoto, et al.
Endocrine Journal|September 24, 2023
Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal of a predictive scoreNatsuko Watanabe, Jaeduk Yoshimura Noh, Ai Kozaki, et al.
Plos One|April 28, 2022
Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppressionHaremaru Kubo, Yuya Tsurutani, Kosuke Inoue, et al.
Scientific Reports|December 11, 2023
Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center studyTakumi Kitamoto, Tsuyoshi Idé, Yuta Tezuka, et al.
Environmental Research|August 27, 2020
Prenatal exposure to perfluoroalkyl substances and behavioral difficulties in childhood at 7 and 11 yearsJiajun Luo, Jingyuan Xiao, Yu Gao, et al.
Journal of the American Heart Association|August 5, 2024
Primary Aldosteronism and Risk of Cardiovascular Outcomes: Genome-Wide Association and Mendelian Randomization StudyKosuke Inoue, Tatsuhiko Naito, Ryosuke Fuji, et al.
Pageof 25